D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 26,510 237 World Ranking 13216 National Ranking 6878

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

Gerald B. Appel spends much of his time researching Kidney disease, Internal medicine, Glomerulonephritis, Pathology and Lupus nephritis. His biological study spans a wide range of topics, including Glomerulosclerosis, Nephrotic syndrome, Surgery and Urology. As part of his studies on Internal medicine, Gerald B. Appel often connects relevant subjects like Gastroenterology.

His Glomerulonephritis research is multidisciplinary, relying on both Monoclonal Immunoglobulin Deposition Disease and Monoclonal. Gerald B. Appel interconnects Membranoproliferative glomerulonephritis, Proteinuria, Renal pathology, Eculizumab and Creatinine in the investigation of issues within Pathology. The concepts of his Lupus nephritis study are interwoven with issues in Cyclophosphamide, Maintenance therapy, Immunology, Lupus erythematosus and Connective tissue disease.

His most cited work include:

  • The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited (1474 citations)
  • Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis (847 citations)
  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study† (763 citations)

What are the main themes of his work throughout his whole career to date?

Gerald B. Appel mainly focuses on Internal medicine, Immunology, Glomerulonephritis, Gastroenterology and Pathology. His work in Internal medicine addresses subjects such as Nephropathy, which are connected to disciplines such as Immunoglobulin A. His Immunology research integrates issues from Lupus nephritis and Disease.

His Glomerulonephritis research is multidisciplinary, relying on both Eculizumab, Immunopathology and Renal pathology. The concepts of his Gastroenterology study are interwoven with issues in Surgery, Retrospective cohort study and Mycophenolate. He interconnects Glomerulosclerosis, Kidney and Glomerulopathy in the investigation of issues within Pathology.

He most often published in these fields:

  • Internal medicine (49.58%)
  • Immunology (22.03%)
  • Glomerulonephritis (22.03%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (49.58%)
  • Gastroenterology (21.61%)
  • Nephropathy (16.10%)

In recent papers he was focusing on the following fields of study:

Gerald B. Appel mainly investigates Internal medicine, Gastroenterology, Nephropathy, Kidney disease and Focal segmental glomerulosclerosis. In general Internal medicine study, his work on Membranous nephropathy, Glomerulonephritis, Renal function and Proteinuria often relates to the realm of In patient, thereby connecting several areas of interest. He has included themes like Autoantibody, Rituximab, Immunology and Renal pathology in his Glomerulonephritis study.

His research in Nephropathy tackles topics such as Randomized controlled trial which are related to areas like Surrogate endpoint. His Kidney disease research includes elements of Exome sequencing, Exome, Emergency medicine and Intensive care medicine. His studies deal with areas such as Nephrotic syndrome, Disease and Allele as well as Focal segmental glomerulosclerosis.

Between 2015 and 2021, his most popular works were:

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (254 citations)
  • Diagnostic Utility of Exome Sequencing for Kidney Disease (147 citations)
  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy (94 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His primary scientific interests are in Internal medicine, Kidney disease, Focal segmental glomerulosclerosis, Nephropathy and Membranous nephropathy. His research links Gastroenterology with Internal medicine. His study in Kidney disease is interdisciplinary in nature, drawing from both Exome sequencing, Exome, Gene expression, Disease and Genotype.

His studies in Nephropathy integrate themes in fields like Randomized controlled trial and Renal function. His Nephrotic syndrome course of study focuses on Urology and Pathology. His Proteinuria research includes themes of Creatinine and Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited

Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan.
Journal of The American Society of Nephrology (2004)

3502 Citations

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

Ellen M. Ginzler;Mary Anne Dooley;Cynthia Aranow;Mimi Y. Kim.
The New England Journal of Medicine (2005)

1261 Citations

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney.
Arthritis & Rheumatism (2012)

1181 Citations

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)

1172 Citations

Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis

Mary Anne Dooley;David Jayne;Ellen M. Ginzler;David Isenberg.
The New England Journal of Medicine (2011)

622 Citations

Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler.
American Journal of Nephrology (2004)

577 Citations

C3 glomerulopathy: consensus report

Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith.
Kidney International (2013)

557 Citations

Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate

Glen S. Markowitz;Gerald B. Appel;Paul L. Fine;Andrew Z. Fenves.
Journal of The American Society of Nephrology (2001)

518 Citations

Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.

Vivette D'Agati;Jung-Il Suh;Laura Carbone;Jen-Tse Cheng.
Kidney International (1989)

513 Citations

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update

Gerald B. Appel;H. Terence Cook;Gregory Hageman;J. Charles Jennette.
Journal of The American Society of Nephrology (2005)

488 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gerald B. Appel

Fernando C. Fervenza

Fernando C. Fervenza

Mayo Clinic

Publications: 123

Sanjeev Sethi

Sanjeev Sethi

Mayo Clinic

Publications: 105

Vivette D. D'Agati

Vivette D. D'Agati

Columbia University

Publications: 96

Brad H. Rovin

Brad H. Rovin

The Ohio State University

Publications: 77

David A. Isenberg

David A. Isenberg

University College London

Publications: 70

Nelson Leung

Nelson Leung

Mayo Clinic

Publications: 69

Giuseppe Remuzzi

Giuseppe Remuzzi

Mario Negri Institute for Pharmacological Research

Publications: 67

Richard J.H. Smith

Richard J.H. Smith

University of Iowa

Publications: 59

Véronique Frémeaux-Bacchi

Véronique Frémeaux-Bacchi

Grenoble Alpes University

Publications: 57

David Jayne

David Jayne

University of Cambridge

Publications: 50

Tak Mao Chan

Tak Mao Chan

University of Hong Kong

Publications: 50

Agnes B. Fogo

Agnes B. Fogo

Vanderbilt University Medical Center

Publications: 48

Glen S. Markowitz

Glen S. Markowitz

Columbia University

Publications: 47

Daniel C. Cattran

Daniel C. Cattran

University Health Network

Publications: 46

Michelle Petri

Michelle Petri

Johns Hopkins University School of Medicine

Publications: 44

Graciela S. Alarcón

Graciela S. Alarcón

University of Alabama at Birmingham

Publications: 41

Trending Scientists

Mehrdad Nourani

Mehrdad Nourani

The University of Texas at Dallas

José-Víctor Ríos-Rull

José-Víctor Ríos-Rull

University of Pennsylvania

Johannes C. Jansen

Johannes C. Jansen

National Research Council (CNR)

Kevin J. Collier

Kevin J. Collier

University of Waikato

Les Kaufman

Les Kaufman

Boston University

Per Sundberg

Per Sundberg

University of Gothenburg

Pierre Ferrier

Pierre Ferrier

Aix-Marseille University

Peter A. Lambert

Peter A. Lambert

Aston University

Roland Brandt

Roland Brandt

Osnabrück University

Allan Hildesheim

Allan Hildesheim

National Institutes of Health

Gareth R. Davies

Gareth R. Davies

Vrije Universiteit Amsterdam

Aijun Ding

Aijun Ding

Nanjing University

Karolina Palucka

Karolina Palucka

Baylor University

Jerold E. Rehg

Jerold E. Rehg

St. Jude Children's Research Hospital

Robert A. Steer

Robert A. Steer

Rowan University

Ben Schöttker

Ben Schöttker

Heidelberg University

Something went wrong. Please try again later.